Regulatory News
Sunday, November 13, 2016
BRIEF-Impedimed Ltd to commence full commercial launch of l- dex in oncology in U.S.
* Poised to commence full commercial launch of l-dex in
oncology in U.S.
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment